{"disease":{"id":"pulmonary-hypertension","name":"Pulmonary hypertension","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":17},"drugs":{"marketed":[{"drug_id":"treprostinil","indication_name":"Thromboembolic pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remodulin","generic_name":"TREPROSTINIL","company_name":"United Therap","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":10,"revenue":"2000","mechanism":"Remodulin works by activating the prostacyclin receptor, which causes blood vessels to relax and widen."},{"drug_id":"treprostinil","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remodulin","generic_name":"TREPROSTINIL","company_name":"United Therap","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":10,"revenue":"2000","mechanism":"Remodulin works by activating the prostacyclin receptor, which causes blood vessels to relax and widen."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"macitentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Opsumit","generic_name":"MACITENTAN","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist [EPC]","quality_score":75,"revenue":"1181.0","mechanism":"Opsumit works by blocking the action of endothelin-1, a protein that causes blood vessels to constrict and increase blood pressure."},{"drug_id":"bosentan","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tracleer","generic_name":"BOSENTAN","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist","quality_score":52,"revenue":null,"mechanism":""},{"drug_id":"prostacyclin","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prostacyclin","company_name":"United Therapeutics","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 12, Prostacyclin receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"prostacyclin","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prostacyclin","company_name":"United Therapeutics","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 12, Prostacyclin receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"ilomedin","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ilomedin","company_name":"Prim PD Dr Afshin Assadian","drug_phase":"phase_2","molecular_target":"Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cialis","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cialis","company_name":"Ottawa Hospital Research Institute","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"nitrogen-nf","indication_name":"Persistent pulmonary hypertension of the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NITROGEN, NF","generic_name":"NITROGEN, NF","company_name":"UNIVERSAL INDUSTRIAL GASES, INC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"adempas","indication_name":"Chronic thromboembolic pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adempas","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1, cAMP-specific 3',5'-cyclic phosphodiesterase 7B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"adempas","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adempas","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1, cAMP-specific 3',5'-cyclic phosphodiesterase 7B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"beraprost","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procylin","generic_name":"BERAPROST","company_name":"","drug_phase":"discontinued","molecular_target":"Prostacyclin receptor","drug_class":"beraprost","quality_score":null,"revenue":null,"mechanism":"Procylin works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow."},{"drug_id":"revatio","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revatio","generic_name":"Sildenafil Citrate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Phosphodiesterase type 5 (PDE5)","drug_class":"PDE5 inhibitor","quality_score":66,"revenue":null,"mechanism":"Sildenafil inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels and enabling penile smooth muscle relaxation."},{"drug_id":"epoprostenol","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flolan","generic_name":"EPOPROSTENOL","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":75,"revenue":null,"mechanism":"Flolan works by binding to the prostacyclin receptor, causing blood vessels to relax and dilate."},{"drug_id":"epoprostenol","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flolan","generic_name":"EPOPROSTENOL","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":75,"revenue":null,"mechanism":"Flolan works by binding to the prostacyclin receptor, causing blood vessels to relax and dilate."},{"drug_id":"ambrisentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Letairis","generic_name":"AMBRISENTAN","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"tolazoline","indication_name":"Persistent pulmonary hypertension of the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasodil","generic_name":"TOLAZOLINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"tolazoline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"selexipag","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uptravi","generic_name":"SELEXIPAG","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacyclin Receptor Agonist [EPC]","quality_score":70,"revenue":null,"mechanism":"Uptravi works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow."},{"drug_id":"selexipag","indication_name":"Thromboembolic pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uptravi","generic_name":"SELEXIPAG","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacyclin Receptor Agonist [EPC]","quality_score":70,"revenue":null,"mechanism":"Uptravi works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow."},{"drug_id":"riociguat","indication_name":"Chronic thromboembolic pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Adempas","generic_name":"RIOCIGUAT","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1","drug_class":"Soluble Guanylate Cyclase Stimulator [EPC]","quality_score":10,"revenue":null,"mechanism":"Adempas works by stimulating the soluble guanylate cyclase enzyme to increase levels of cyclic guanosine monophosphate (cGMP), a signaling molecule that helps to relax blood vessels."},{"drug_id":"riociguat","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Adempas","generic_name":"RIOCIGUAT","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1","drug_class":"Soluble Guanylate Cyclase Stimulator [EPC]","quality_score":10,"revenue":null,"mechanism":"Adempas works by stimulating the soluble guanylate cyclase enzyme to increase levels of cyclic guanosine monophosphate (cGMP), a signaling molecule that helps to relax blood vessels."},{"drug_id":"sitaxsentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sitaxsentan","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Endothelin B receptor, Endothelin-1 receptor, Endothelin-1 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"ventavis","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ventavis","company_name":"Meshalkin Research Institute of Pathology of Circulation","drug_phase":"phase_2","molecular_target":"Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sotatercept-csrk","indication_name":"Pulmonary Arterial Hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"WINREVAIR","generic_name":"SOTATERCEPT-CSRK","company_name":"MERCK SHARP DOHME","drug_phase":"marketed","molecular_target":"activin A and other TGF-β superfamily ligands","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Sotatercept-csrk binds to activin A and other TGF-β superfamily ligands, improving the balance between pro-proliferative and anti-proliferative signaling to modulate vascular proliferation."},{"drug_id":"sildenafil","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Viagra","generic_name":"sildenafil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Multidrug resistance-associated protein 5","drug_class":"PDE5 inhibitor","quality_score":null,"revenue":null,"mechanism":"Selectively inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels to relax smooth muscle in the corpus cavernosum and pulmonary vasculature."},{"drug_id":"tadalafil","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cialis","generic_name":"tadalafil","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"Phosphodiesterase 5 Inhibitor [EPC]","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"nitric-oxide","indication_name":"Persistent pulmonary hypertension of the newborn","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inomax","generic_name":"NITRIC OXIDE","company_name":"Vero Biotech Inc","drug_phase":"marketed","molecular_target":"Soluble guanylate cyclase","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"nitric-oxide","indication_name":"Pulmonary hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inomax","generic_name":"NITRIC OXIDE","company_name":"Vero Biotech Inc","drug_phase":"marketed","molecular_target":"Soluble guanylate cyclase","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"bosentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tracleer","generic_name":"BOSENTAN","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist","quality_score":52,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":31,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05329714","title":"PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":40000,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT04684836","title":"Comparative Effectiveness of Telemedicine in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":33100,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT07532564","title":"Risk Factors, Costs, and Impacts of ED Boarding","phase":"","overall_status":"COMPLETED","enrollment_count":30486,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT03974919","title":"Preoperative Pulmonary Systolic Pressure and Outcome After Non-cardiac Surgery:Threshold Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":19000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT01347216","title":"COMPERA / COMPERA-KIDS","phase":"","overall_status":"RECRUITING","enrollment_count":14000,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT05039086","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5","phase":"","overall_status":"COMPLETED","enrollment_count":13021,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT06954727","title":"China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT06476470","title":"Taiwan Interstitial Lung Disease Multi-center Investigation and Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT05958901","title":"Pulmonary Hypertension Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07082933","title":"Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06135909","title":"CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Chinese Pulmonary Vascular Disease Research Group","has_results":false},{"nct_id":"NCT07477197","title":"Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT04654650","title":"Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06186713","title":"Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular Function","phase":"","overall_status":"COMPLETED","enrollment_count":4784,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06739057","title":"Pediatric Ventricle Function Assessment Study","phase":"","overall_status":"COMPLETED","enrollment_count":3993,"lead_sponsor_name":"HBI Solutions Inc.","has_results":false},{"nct_id":"NCT03959748","title":"DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Polish Cardiology Association","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT02126943","title":"OPsumit USers Registry","phase":"","overall_status":"COMPLETED","enrollment_count":2686,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT06386185","title":"Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Royal United Hospitals Bath NHS Foundation Trust","has_results":false},{"nct_id":"NCT06784687","title":"Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease","phase":"","overall_status":"COMPLETED","enrollment_count":2376,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03197688","title":"Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT03719027","title":"Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2003,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03169010","title":"Registration Study for Rare Type of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT04930289","title":"Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Paragonix Technologies","has_results":false},{"nct_id":"NCT05566002","title":"Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese Pulmonary Vascular Disease Research Group","has_results":false},{"nct_id":"NCT05198206","title":"Pregnant Women With Pulmonary Hypertension in China","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT03185572","title":"Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1708,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT03883048","title":"Idiopathic Bronchiectasis and Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1606,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT05311072","title":"Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT06526468","title":"Chinese PE Multimodality Imaging Artificial Intelligence Study","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03451630","title":"Integrated Care (IC) Models for Patient-Centered Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"University of Pittsburgh","has_results":true},{"nct_id":"NCT07344207","title":"GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1380,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT04681014","title":"CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation","phase":"","overall_status":"UNKNOWN","enrollment_count":1218,"lead_sponsor_name":"iPHNET (italian Pulmonary Hypertension NETwork)","has_results":false},{"nct_id":"NCT04007653","title":"Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT07164157","title":"The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Wei Huang","has_results":false},{"nct_id":"NCT01106014","title":"Selexipag (ACT-293987) in Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1156,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT03134898","title":"Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1025,"lead_sponsor_name":"Sociedad Española de Neumología y Cirugía Torácica","has_results":false},{"nct_id":"NCT03364244","title":"Revatio Special Investigation for Long-term Use in Pediatric Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1023,"lead_sponsor_name":"Viatris Pharmaceuticals Japan Inc","has_results":false},{"nct_id":"NCT07102823","title":"Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT07131241","title":"PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT05368467","title":"National Registry and Cohort Study of Pulmonary Vascular Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03051763","title":"The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT07147725","title":"Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection Using Artificial Intelligence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT00011648","title":"Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia","phase":"","overall_status":"COMPLETED","enrollment_count":986,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04273945","title":"Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":935,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT06388421","title":"DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT05679206","title":"Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT01027949","title":"An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":894,"lead_sponsor_name":"United Therapeutics","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}